期刊文献+

中国制药行业应对授权仿制药挑战的对策 被引量:4

原文传递
导出
摘要 目的:通过对典型国家授权仿制药情况的研究,期望推动我国的相关研究并完善我国的相关政策法规。方法:按现有法规推进对授权仿制药的政策研究。结果:授权仿制药作为一种特殊的仿制药,是品牌药厂商抢占中国仿制药市场的重要工具。长期来看,授权仿制药将会对我国仿制药市场竞争产生消极影响,降低我国制药企业的积极性。结论:即将到来的专利悬崖会对全球制药行业产生深远的影响。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2012年第22期1831-1835,共5页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金项目(编号:71003037) 教育部人文社会科学研究一般项目(编号:11YJA630224)
  • 相关文献

参考文献20

  • 1Krizner K. Major Brand-Name drugs face patent expiration[N/ OL]. Drug Topics, Mar 15, 2011(2011-12 10). http://drug- topics, modernmedicine, com/drugtopies/Modern + Medicine + Now/Major-brand-name-drugs-face-patent-expirafion/Arti- eleStandard/Artiele/detail/711836.
  • 2Big Pharma's 2009-2013 Patent Cliff [ER/OL](2011-12-10). ht-tp://aladinrc, wrlc. org/bitstream/1961/9359/1/Jardines, %o20Ben% 20- %20Spring%2010 %20 (P). pdf.
  • 3Gebhart, F. Generics continue to roll up medication markets [N/OL]. Drug Topics , 2011,155 (8) (2012-5-2). http:// drugtopics, modernmedieine, com/drugtopics/Modern + Medi cine + Now/Generics-continue-to roll ul~medication-markets/ ArticleStandard/Article/detail/735335.
  • 4DiMasi JA, Henry G. The cost of biopharmaceutical R&D: Is biotech different? [J]. Managerial and Decision Econ, 2007, 28 : 469-476.
  • 5Scott C. An aggregate approach to antitrust: Using new data and rulemaking to preserve drug competition [J]. Columbia Law Review, 2009,109 (5) : 665.
  • 6Singer,N. Generics Face Longer Wait for Approval[N/OL]. N.Y. TIMES (2012-3-30). http://www, nytimes, com/2010/ 02/20/business/20generics. html.
  • 7FDA拟征仿制药UserFee加快审批速度[EB/OL].(2012-3-30).http: //www.dxyer.cn/jinwsapa/2012/01n9/fda-nikaizheng-fang-zhi-yao-user/.
  • 8Hess J. Battle for the Market: Branded drug companies'secret weapons generic drug makers must know[J]. J Generic Med, 2005,3(8) :20-29.
  • 9Hollis A. The Anti-competitive effects of Brand-Controlled "Pseudo-Generics" in the Canadian pharmaceutical market[J]. Canadian Public Policy/Analyse de Politiques, 2003,29 ( 1 ) : 21- 30.
  • 10Levy S. Why Authorized generics are Making a comeback[N/ OL]. Drug Topics: The online newspaper for pharmacists (2011-11-5 ). http://www, drugtopics, com/drugtopics/arti cle/articleDetail, jsp? id = 111159.

同被引文献47

  • 1齐燕,高东平,杨渊.我国医药专利70年发展态势分析[J].医学信息学杂志,2019,40(10):19-24. 被引量:4
  • 2刘立春,朱雪忠.与药品专利强制许可相关的“公共健康”含义[J].中国卫生经济,2015,34(2):73-78. 被引量:16
  • 3马海生.遗传资源保护与专利申请中遗传资源披露——兼评《专利法修订草案》中的相关条款[J].知识产权,2007,17(3):37-41. 被引量:8
  • 4新华网.胡锦涛在党的十七大上的报告[EB/OL].Http://news.xinhuanet.com/newscenter/2007-10/24/content_6938568.htm;2007-10-24.
  • 5American First Amendment : Congress shall make no law respecting an establishment of religion, or prohibi- ting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of thepeople peaceably to assemble, and to petition the Government for a redress of grievances.
  • 6Matthew Avery, William Newsom, Brian Hahn: The antitrust implications of filing "SHAM" citizen peti- tions with the FDAF J1. Hastinzs Law Journal. V01.65. No. 113. 2013.
  • 7王宇.仿制药领域上演华丽的冒险[N].中国医药报,2013,(10):9.
  • 8http :// www. fdalawblog, net/fda_ law _ blog_ hyman_ phelps/files/CPTracker, xls , FDA Citizen Petition Tracker, FDA Law Blog, (Oct. 2, 2013).
  • 9Kurt R. Karst, Introducing the FDC Act ~ 505(q) Citizen Petition Tracker[ EB/OL].available at http:// www. fdalawblog, net/fda_law_blog hyman_phelps/2008/ 10/introducing - the. html, visited on Oct, 2013,.
  • 10Professional Real Estate Investors v. Columbia Pictures Industry, Inc. , 508 U.S. 49, 1993.

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部